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Summary
We describe an immunoadhesin molecule containing intercellular adhesion molecule 1 (ICAM-1)
molecularly fused to hinge and C2 and C3 domains of the human immunoglobulin G1 H
chain that binds Plasmodiumfalciparum-infected erythrocytes. This receptor-based immunoadhesin
is an effective and specific inhibitor ofP .fkiparum-infected erythrocyte adhesion to ICAM-1-bearing
surfaces, but does not inhibit leukocyte function antigen 1 (LFA-1) interaction with ICAM-1.
Furthermore, the immunoadhesin promotes phagocytosis and destruction of parasitized erythrocytes
by human monocytes. Each of these modes of action has potential for the therapy of malaria.
I
ntercellular adhesion molecule 1(ICAM-1) belongs to the
Ig superfamily of proteins and is primarily involved in
cell-cell adhesive interactions of the immune system (1).
ICAM-1 expression on postcapillary endothelium is regulated
by the cytokines TNF and ILA (2) . ICAM-1 functions as a
natural receptor for the integrins lymphocyte function an-
tigen 1 (LFA-1) (3) and Mac-1 (4, 5). In addition, this versa-
tile molecule is exploited as a receptor for the major group
ofhuman rhinoviruses (6, 7) and for Plasmodiumfalciparum-
infected erythrocytes (8, 9). Recently, we and others have
demonstrated that red blood cells infected with mature in-
tracellular forms of the malaria parasite (IRBC) bind to a
region located within the NH2-terminal Ig-like domain of
ICAM-1 that is distinct from the regions recognized by LFA1
and rhinovirus (10, 11) .
The adherence of erythrocytes infected with the human
malaria parasite, P. falciparum to postcapillary venular en-
dothelium in peripheral tissues avoids clearance in the spleen
and contributes to evasion of the host immune response, as
well as to the pathogenesis of cerebral malaria. Disruption
of intravascular erythrocyte sequestration is predicted to al-
leviate much of the pathology of P . falciparum malaria, and
especially mortality, as a result of severe cerebral malaria or
placental insufficiency. Sequestration involves interactions be-
tween multiple endothelial receptors and counter-receptors
on the parasitized erythrocyte surface. ICAM-1 and CD36
bind infected erythrocytes from a majority of patients with
uncomplicated and severe forms ofthe disease (8, 9) . Disrup-
tion of these adhesion pathways may be an effective alterna-
tive to chemotherapy for treating the increasing number of
drug-resistant strains of P. fkiparum. Previously, we have
demonstrated that soluble ICAM-1 and synthetic ICAM-1
peptides may compete IRBC binding to ICAM-1 (10). Here
we characterize an ICAM-1 immunoadhesin that both com-
petes adherence and triggers immunologic killing of IRBC.
Materials and Methods
Construction ofan ICAM-1 Immunoadhesin.
￿
A 1.3 kb fragment
containing the 71 hinge, C.2 and C3 sequence was generated by
PCR from a plasmid containing the human gene (12) using oligo-
nucleotideprimers 5'TTTCTCGA000TGTCTGCTGGAAGCAG-
GCTCAGand5'TTTGCGG000CGGGAGCGGGGCTTGCC-
GGCCGTCG. The 5' Xhol and 3' Notl sites introduced by the
primers were used to subclone the IgG1 sequence into pCDM8
to produce pCDG1. To construct an ICAM-1-IgGl chimera, a PCR
fragment was generated that contains the ICAM-1 cDNA sequence
for signal peptide and domains 1 and 2 terminating with the codon
F185 (13) using primers 5'A000GAAGCTTCTAGAGATCCCTC-
GACCACGAGATCCATTGTGC and 5'TTTCTCGAGTCTCAC-
CAAAGGTCTGGAGCTGGTAGGGGGC. The fragment contains
a 5' HindIII site, a translational stop codon following the codon
for F185, the 5' donor splice that follows the -y1 C1 exon, and
a 3' Xhol site. This fragment was subcloned into HindlII and Xhol
sites of pCDG1 to produce pCDF185G1. Culture supernatants of
COS cells transfected with pCDF185G1 contained -0.5 gg/ml
ICAM-1-IgGl chimera (1C1-2D/IgG) as determinedby ELISA on
day 3 after transfection. IC1-2D/IgG was purified from culture
media of transfected COS cells by ICAM-1 mAb (R6.5)-Sepharose
and protein A-Sepharose chromatography.
P. falciparum-infected Erythrocyte and Lymphoblastoid Cell Binding
to ICAM-1.
￿
Soluble ICAM-1 truncated before the hydrophobic
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1471-1476transmembrane region was purified from the supernatants of trans-
fected CHO cells (sICAM-1/CHO) (14) or baculovirus vector-
infected insect cells (15) . For IRBC binding, ICAM-1 (10 lag/ml)
was adsorbed (20 /Al aliquots) to plastic bacteriological plates (model
1007 ; Falcon Labware, Oxnard, CA) overnight at 4°C. IC1-2D/IgG
(ICAM-1-IgGl chimera) was similarly adsorbed to plastic plates
that hadpreviously been coated with protein A (50 Ag/ml) . Un-
bound sites were blocked for 30 min at room temperature with
1% BSA-PBS to reduce nonspecific binding . Laboratory-adapted
intraerythrocytic P . falciparum parasites selected in vitro to bind to
purified ICAM-1 (ItG-ICAM) (9) were maintained in synchronous
continuous culture andused in adhesion assays at the trophozoite/
schizont stage of development . The IRBC were added to ICAM-
1-coated plates (40-50% parasitemia, 1% hematocrit) for 1 h at
room temperature . In inhibition assays, ItG-ICAMIRBC were in-
cubated in solution with increasing concentrations of ICl-2D/IgG
chimera, sICAM-1/CHO, or normal human IgG for 30 min be-
fore addition to plates coated with sICAM-1/CHO (10 NLg/ml) .
Erythrocytes not attached to the sICAM-1-coated surface were re-
moved by gentle rinsing of the plates. Cells were fixed with 2%
glutaraldehyde and stained with Giemsa . The number of malaria-
infected erythrocytes bound per mmz surface area represents the
mean of three separate determinations. The concentration of
sICAM-1 andIC1-2D/IgG was determined with a capture ELISA
assay (14), using sICAM-1/CHO as a standard .
ForSKW3 cell binding, ICl-2D/IgG at the concentration in-
dicated was absorbed to 96-well microtiter plates that had previ-
ously been coated with protein A (20 pg/ml) and blocked with
1% BSA-PBS .SKW3 cells in binding buffer (RPMI/10% FBS/20
mM Hepes) were treated with or without 100 ng/ml PMA for
15 min at 37°C andthen labeled with 2;7'-bis(2-carboxyethyl)-(5
and 6)-carboxyfluorescein acetomethyl ester (Molecular Probes, Inc .,
Eugene, OR). Binding (105 cells/well) was for 1 h at 25°C.
For IC1-2D/IgG inhibition of SKW3binding, 96-well micro-
titer plates were coated with 50 I1 sICAM-1(10 Fig/ml, 2 h, 37°C)
and blocked with 1% BSA-PBS . PMA-treated SKW3 (105 cells)
were incubated for 30 min in 50 Al of binding buffer, with or
without IC1-2D/IgG ormAbTS1/18 to theLFA-1 (3 subunit (1:100
ascites) andthen added directly to sICAM-1-coated wells . Binding
was for 1 h at 37°C . Unbound cells were removed by inverting
microtiter plates in a tank of PBS/1 mM Mg2+/0.05 mM
Ca"/0.1% BSA for 45 min . Bound cells were quantitated on a
fluorescence concentration analyzer (Pandex Laboratories Inc., Mun-
delein, IL). Percent bound (±SD) was calculated by subtracting
background binding to wells that were not coated with ICAM-1
from binding to ICAM-1-coated wells, divided by input fluores-
cence x 100 .
Monocyte Phagocytosis ofP .falciparum-infected Erythrocytes.
￿
Human
mononuclear cells isolated from wholebloodby centrifugation on
a Ficoll-Hypaque density gradient were washed three times in RPMI
1640 andresuspended in medium supplemented with 10% normal
human serum . Cells (105 in 100 td) were added to glass coverslips
for 90 min at 37°C in 7.5% CO 2 . Nonadherent cells were re-
moved by washing coverslips three times. Attached cells were >95%
monocytes by Wright-Giemsa and esterase stains . IRBC (5 x 106
per 100 g1) selected in vitro for binding to ICAM-1 (ItG-ICAM)
or CD36 (ItG-CD36) were incubated with ICl-2D/IgG chimera
or normal human IgG (20 Fog/ml final concentration) for 30 min
before addition to monolayers of adherent freshly isolated human
monocytes . After 2 h incubation at 37°C, unattached red blood
cells were removed by washing coverslips three times with RPMI
1640 . To avoid quantitating IRBC attached to thephagocyte sur-
face but not internalized, coverslips were rinsed in hypotonic0.85%
1472
NH 4C1 to lyse attached IRBC . Preincubation of monocyte
monolayers with anti-CD36mAbOKM5 completely blocked adhe-
sion ofItG-CD36-infected erythrocytes to monocyteswithout any
effect on subsequent phagocytosis of ItG-ICAM malaria-infected
erythrocytes (not shown) . Coverslips were fixed with2% glutaralde-
hyde followed by staining with Giemsa . The percentage of mono-
cytes that contained intracellular intact infected red cells or degraded
parasite pigment was quantitated by light microscopy.
Results
Since adhesion ofIRBC to microvascular endothelium is
an absolute requirement for survival ofP . falciparum parasites
in vivo (16), a strategywasfashioned to both inhibit infected
Figure 1 .
￿
(a) Schematic diagram of the IC1-2D/IgG expression con-
struct (pCDF185G1) and the ICl-2D/IgG immunoadhesin . (b) SDS-PAGE
of the immunoadhesin. COS cells were transfected with the plasmid
pCDF185G1 or as a control CDM8 and labeled with [35S]methionine and
cysteine. Secreted material was precipitated with protein A-Sepharose and
subjected to SDS-PAGE and fluorography. Identical results were obtained
withimmunoprecipitations using anti-ICAM-1mAbR6 .5 (data not shown).
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erythrocyte adhesion and kill the intracellular parasite. We
designed an immunoadhesin consisting of the first two
NH2-terminal Ig-like domains of ICAM-1 fused to the
hinge region and CH2 and C3 domains of human IgG1 H
chain and expressed it in COS cells (Fig . 1 a) . The secreted
mature immunoadhesin, IC1-2D/IgG, exists as a dimer
migrating at 140,000M r when not reduced, and 70,000M *
when reduced (Fig. 1 b) . These sizes agree with that predicted
for IC1-2D/IgG.
The adhesion of IRBC to IC1-2D/IgG immunoadhe-
sin was compared with that of a soluble form of ICAM-1
(sICAM-1) possessing all five Ig-like domains that was pro-
duced inCHO cells (14) or insect cells (15) . Malaria-infected
erythrocytes bind in a dose-dependent manner to sICAM-1
and IC1-2D/IgG coated on surfaces (Fig . 2 A) . The immu-
noadhesin did not bind uninfected erythrocytes or erythro-
cytes infected with malaria parasites which bind to an alter-
native endothelial receptor, CD36 (data not shown) . The
ICAM-1 immunoadhesin is amore effective inhibitor ofIRBC
adhesion to an ICAM-1-coated surface than sICAM-1 (Fig. 2
B) . The K ; for IC1-2D/IgG is -20 nM, whereas for
sICAM-1 it is 150 nM (10) . Enhanced binding may reflect
the divalent nature of IC1-2D/IgG .
Binding of IC1-2D/IgG to IRBC was compared with
binding to LFA-1 on the T lymphoblastoid line SKW3.
SKW3 cell adherence to immobilized IC1-2D/IgG is enhanced
by PMA (Fig. 2 C), in similarity to results with immobi-
lized ICAM-1 (17) . Concentrations of soluble IC1-2D/IgG
as high as 150 nM do not inhibit LFA-1-dependent SKW3
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Figure 2 .
￿
P .falciparum-infected erythrocyte and
Tlymphoblastoid cell binding to recombinant
ICAM-1 . (A) Adhesion of ItG-ICAM-1-IRBC to
surfaces coated with the indicated concentrations
of ICAM-1-IgG chimera (ICI-2D/IgG), CHO cell-
derived soluble ICAM-1 and baculovirus-derived
soluble ICAM-1 . (B) Inhibition ofIRBC adhesion
to ICAM-1-coated surfaces by IC1-2D/IgG chi-
mera, sICAM-1, or human IgG . (C) Binding of
T lymphoblastoid cells ± PMA to ICl-2D/IgG
coated surfaces. (D) Inhibition ofPMA-stimulated
SKW3 adhesion to sICAM-1-coated surface by
IC1-2D/IgG.
binding to sICAM-1-coated surfaces (Fig . 2 D) . In addition,
binding of soluble IC1-2D/IgG to lymphoblastoid cells with
or without PMA treatment cannot be detected by indirect
immunofluorescence (data notpresented) . Adhesion receptors
have been found to be of low affinity, on the order of 1 ILM
(18, 19). These findings show that the affinity ofIC1-2D/IgG
is higher for the receptor on IRBC than forLFA-1 . This differ-
ence in affinity should make it possible to use IC1-2D/IgG
to disrupt sequestration ofIRBC through ICAM-1 without
Figure 3 .
￿
Phagocytosis ofP .falciparum-infected erythrocytes by human
monocytes. P . falciparum-infected erythrocytes selected for binding to
ICAM-1(ItG-ICA" or CD36 (ItC-CD36) were incubated with ICl-2D/
IgG chimera or normalhuman IgG before addition to monolayers offreshly
isolated human monocytes . After 2 h, noninternalized IRBC were lysed
and monocytes with intracellular infected red cells or degraded parasite
pigment were quantitated by staining with Giemsa and light microscopy.
Results indicate the mean ± SD of three determinations.
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Ddisrupting ICAM-1/LFA-1 interactions that are important
in inflammation and the immune response.
We tested the ability ofICAM-1 immunoadhesin to sup-
port phagocytosis ofIRBC . The Fc region ofIgG1 was chosen
for the immunoadhesin because this subclass is the most effec-
tive in triggering antibody-dependent cellular cytotoxicity
(20) and binds avidly to all three classes of Fcy receptor (21) .
Incubation ofparasitized erythrocytes that bind to ICAM-1
(ItG-ICAM IRBC) with the IC1-2D/IgG chimera resulted
in their phagocytosis suggesting that the FcR binding func-
tion of IC1-2D/IgG is intact (Fig . 3) . Infected erythrocytes
incubated with or without normal human IgG were not
phagocytosed. C1336-binding IRBC incubated in the pres-
ence or absence of IC1-2D/IgG chimera were not phagocy-
tosed . The IC1-2D/IgG-treated internalizedIRBC are quickly
degraded and residual parasite-derived hemozoin pigment ob-
served intracellularly (Fig . 4, b and c) . CD36-binding IRBC
attach to CD36 on the surface of monocytes but are not
phagocytosed through this receptor (Fig. 4 a) . The rosetting
ofItG-CD36 IRBC with monocytes was blocked completely
by the anti-CD36 mAb OKM5 (data not shown) . The ICAM-
1-binding IRBC are not rosetted or phagocytosed in the ab-
sence of IC1-2D/IgG (Fig. 4 d) .
Discussion
We have designed an ICAM-1 immunoadhesin that is effec-
tive against P . falciparum parasitized erythrocytes at concen-
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